Home Search
Nuclear medicine - search results
If you're not happy with the results, please do another search
Medical imaging – revolutionising healthcare
Professor Alison Murray, Director of the Aberdeen Biomedical Imaging Centre, University of Aberdeen, explains how medical imaging has transformed healthcare over the years
Modern imaging is an essential part of healthcare and has come a long way since the discovery of X-rays in 1895 by Wilhelm Roentgen. Developments by researchers...
Cancer imperialism – how to diagnose bone metastases?
Cancer is an unreliable disease. Just as you think you are familiar with it and can begin treating and hopefully curing it, it is no longer as you thought it was.
It has coloured its hair, carries other garments, or has changed its lifestyle making it unrecognisable and impossible...
Innovative brain imaging
Energy defects, neuroinflammatory processes, and abnormal cellular morphology in neurodegenerative diseases (ND) would constitute extremely informative brain imaging biomarkers of disease progression and readouts in clinical trials. Emerging research aims at developing novel brain imaging methods to study these different aspects not only in animal models but also in...
Manchester researchers secure ERC Grants for ground-breaking scientific projects
Seven Manchester researchers have been awarded prestigious European Research Council (ERC) advanced grants for ambitious, curiosity-driven scientific projects in an effort to support scientific breakthroughs.
Potential infertility treatment: Skin cells transformed into viable eggs
A new technique by researchers at Oregon Health & Science University (OHSU) could change the infertility treatment .
Engineered endosymbionts as novel cancer therapeutics
Satyajit Hari Kulkarni and Christopher H. Contag from the Institute for Quantitative Health Science and Engineering focus on engineered endosymbionts, which they argue is a paradigm shift in anticancer bacteriotherapy toward killing tumors from the inside out.
Lessons from Libby: Understanding the impact of asbestos exposure
Jean C. Pfau, Scientific Consultant at the Center for Asbestos Related Disease, shares the devasting story of asbestos exposure occurring in a Rocky Mountain town of Montana and the critical lessons that can be learned from this event.
Dr Jean Pfau and the Center for Asbestos Related Disease (CARD)
Jean C. Pfau is an immunotoxicologist with a PhD in Microbiology and Biochemistry. Dr Pfau currently serves as a scientific consultant for the Center for Asbestos Related Disease (CARD) in Libby, Montana.
Youth as essential problem-solvers of our futures
Nancy Butler Songer, Associate Provost of STEM Education at the University of Utah, discusses the importance of supporting and including young people as part of environmental decision-making teams and key problem-solvers of our futures.
How COVID-19 triggers Mitochondrial Dysfunction across organs
COVID-19's hidden impact: Unmasking Mitochondrial Dysfunction across organ systems Since COVID-19, researchers have been perplexed by this.
The History of Science: A Q&A with Professor Ute Deichmann
Professor Ute Deichmann, Jacques Loeb Centre for the History and Philosophy of the Life Sciences, shares some of her expertise of the history of science, with a particular focus on misconceptions and threats to modern day science.
Asia Analysis April 2023
You are warmly invited to the Spring edition of Asia Analysis, a compelling assortment of profoundly absorbing policy articles on many subjects.
Targeting the Cannabinoid Type-2 Receptor for Novel Anto-inflammatory Therapeutics
Type-2 cannabinoid receptor (CB2R) is a G-protein-coupled receptor (GPCR) and an essential element of the endocannabinoid system (ECS) [1].
HIV therapeutic targets: Basic virology to the discovery of antiretroviral drugs
Do we need new antiretroviral drugs to treat HIV infection, and if so, what are the promising targets? Dr Eric O. Freed, Director of the HIV Dynamics and Replication Program at the National Cancer Institute in Frederick, Maryland, discusses these questions.
Decarbonising the NHS hospital estate – Towards net zero
Richard Spencer, Construction and Operation & Maintenance Director at E.ON, details decarbonising your hospital estate in the road towards net zero.
Genomic instability in cancer
In this eBook, Sabine Mai from the University of Manitoba explores how nuclear architecture enables the analysis of genomic instability in cancer.
Upregulation of hnRNPC1/C2 expression in preeclampsia: a potential rationale for vitamin D insensitivity
Drs Yuping Wang and David F. Lewis from Louisiana State University Health Sciences Center – Shreveport discuss hnRNPC1/C2 upregulation, a potential rationale for vitamin D insensitivity.
Overconfidence lends itself to anti-scientific views
Overconfidence bolsters anti-scientific views as the further an individual strays from science, the stronger their opinions become.
Three rare brain diseases that attack your language skills
According to NorthWestern Medicine, there are three different brain diseases that attack the language areas in the left hemisphere of the brain.
The Ukraine war highlights the need for a fast radiation blood test
Dr Quinton Fivelman, Chief Scientific Officer at London Medical Laboratory, says fighting near Ukraine’s nuclear power facilities brings home the need for a rapid radiation blood test.